[ 18 F]mFBG PET/CT imaging outperforms MRI and [ 68  Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma.

MLA

Suurd, Diederik P. D., et al. “[ 18 F]MFBG PET/CT Imaging Outperforms MRI and [ 68  Ga]Ga-DOTA-TOC PET/CT in Identifying Recurrence Pheochromocytoma.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 50, no. 5, Apr. 2023, pp. 1538–40. EBSCOhost, https://doi.org/10.1007/s00259-022-06064-5.

APA

Suurd, D. P. D., Poot, A. J., van Leeuwaarde, R. S., Windhorst, A. D., Vriens, M. R., & de Keizer, B. (2023). [ 18 F]mFBG PET/CT imaging outperforms MRI and [ 68  Ga]Ga-DOTA-TOC PET/CT in identifying recurrence pheochromocytoma. European Journal of Nuclear Medicine and Molecular Imaging, 50(5), 1538–1540. https://doi.org/10.1007/s00259-022-06064-5

Chicago

Suurd, Diederik P D, Alex J Poot, Rachel S van Leeuwaarde, Albert D Windhorst, Menno R Vriens, and Bart de Keizer. 2023. “[ 18 F]MFBG PET/CT Imaging Outperforms MRI and [ 68  Ga]Ga-DOTA-TOC PET/CT in Identifying Recurrence Pheochromocytoma.” European Journal of Nuclear Medicine and Molecular Imaging 50 (5): 1538–40. doi:10.1007/s00259-022-06064-5.